Back to Peptide Encyclopedia
Cognitive EnhancementStrong Evidence
Selank
Anxiolytic neuropeptide approved in Russia, derived from tuftsin.
Prescription3 protocols
Approved by select regulatory agencies — not FDA/EMA
·Educational information. Not medical advice or a recommendation for use.Key Facts: Selank
Category
Cognitive Enhancement
Evidence
Strong Evidence
Availability
Prescription
Protocols
3
Research Overview & Mechanisms
Modulates GABAergic signaling and immune responses.
Reported Research Benefits
Anxiolytic
Cognitive enhancement
Immunomodulation
Available Protocols
Frequently Asked Questions
FAQ
Anxiolytic neuropeptide approved in Russia, derived from tuftsin.
Advanced Compound Intelligence
—
Human studies
—
Key studies
—
Interactions
Strong Evidence
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Strong Evidence
View all studies on PubMedSupported by multiple randomized controlled trials and systematic reviews.
Scientific Sources & Further Reading
Explore peer-reviewed research about Selank:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →